Corrigendum: Ex vivo modulation of intact tumor fragments with anti-PD-1 and anti-CTLA-4 influences the expansion and specificity of tumor-infiltrating lymphocytes

Thomas Morgan Hulen; Christina Friese; Nikolaj Pagh Kristensen; Joachim Stoltenborg Granhøj; Troels Holz Borch; Marlies J W Peeters; Marco Donia; Mads Hald Andersen; Sine Reker Hadrup; Inge Marie Svane; Özcan Met

doi:10.3389/fimmu.2024.1462081

Corrigendum: Ex vivo modulation of intact tumor fragments with anti-PD-1 and anti-CTLA-4 influences the expansion and specificity of tumor-infiltrating lymphocytes

Front Immunol. 2024 Jul 18:15:1462081. doi: 10.3389/fimmu.2024.1462081. eCollection 2024.

Affiliations

¹ National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark.
² Department of Health Technology, Technical University of Denmark, Lyngby, Denmark.

^# Contributed equally.

Abstract

[This corrects the article DOI: 10.3389/fimmu.2023.1180997.].

Keywords: DNA Barcoding; adoptive cell immunotherapy; cancer immunotherapy; checkpoint inhibition; metastatic melanoma; tumor microenevironment; tumor-infiltrating lymphocyte (TIL).

Publication types

Published Erratum